ProfileGDS4095 / 222051_s_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 43% 43% 39% 34% 42% 42% 38% 42% 44% 45% 39% 40% 41% 31% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep12.9709643
GSM709769LY2 SRC1-siRNA tamoxifen treated rep32.9319343
GSM709765LY2 SRC1-siRNA untreated rep32.7141439
GSM709771LY2 SRC1-siRNA untreated rep12.4914334
GSM709772LY2 SRC1-siRNA untreated rep22.8752742
GSM709775LY2 SRC1-siRNA untreated rep42.8554742
GSM709764LY2 control-siRNA tamoxifen treated rep22.6846838
GSM709766LY2 control-siRNA tamoxifen treated rep32.8668442
GSM709768LY2 control-siRNA tamoxifen treated rep13.0283744
GSM709777LY2 control-siRNA tamoxifen treated rep43.0448645
GSM709770LY2 control-siRNA untreated rep32.6864539
GSM709773LY2 control-siRNA untreated rep12.759740
GSM709774LY2 control-siRNA untreated rep22.8059641
GSM709776LY2 control-siRNA untreated rep42.4057931